Oramed Pharmaceuticals
(NASDAQ) ORMP
Oramed Pharmaceuticals Financials at a Glance
Market Cap
$138.91M
Revenue (TTM)
$2.00M
Net Income (TTM)
$43.85M
EPS (TTM)
$1.00
P/E Ratio
3.48
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$3.47
Volume
2,165
Open
$3.58
Price
$3.47
Volume
2,165
Open
$3.58
Previous Close
$3.47
Daily Range
$3.47 - $3.58
52-Week Range
$1.82 - $3.76
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$3.47
Volume
2,165
Open
$3.58
Previous Close
$3.47
Daily Range
$3.47 - $3.58
52-Week Range
$1.82 - $3.76
ORMP News
ORMP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Oramed Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
13
CEO
Nadav Kidron, MBA
Website
www.oramed.comHeadquarters
New York City, NY 10036, US
ORMP Financials
Key Financial Metrics (TTM)
Gross Margin
-4%
Operating Margin
-7%
Net Income Margin
22%
Return on Equity
24%
Return on Capital
-6%
Return on Assets
20%
Earnings Yield
28.74%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$138.91M
Shares Outstanding
39.80M
Volume
2.17K
Short Interest
0.00%
Avg. Volume
209.47K
Financials (TTM)
Gross Profit
$193.00K
Operating Income
$12.78M
EBITDA
$14.87M
Operating Cash Flow
$8.41M
Capital Expenditure
$18.00K
Free Cash Flow
$8.43M
Cash & ST Invst.
$141.93M
Total Debt
$372.00K
Oramed Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$31.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$138.91M
N/A
Market Cap/Employee
$10.69M
N/A
Employees
13
N/A
Net Income
$48.40M
+346.7%
EBITDA
$59.48M
+2058.6%
Quarterly Fundamentals
Net Cash
$133.83M
-5.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$589.00K
+216.7%
Short Term Debt
$271.00K
+11.5%
Return on Assets
19.89%
N/A
Return on Invested Capital
-6.07%
N/A
Free Cash Flow
$1.99M
+71.9%
Operating Cash Flow
$1.99M
+71.9%